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ABSTRACT Thy-i is a plasma membrane protein, but its
primary structure lacks the typical membrane-spanning se-
quence. Recent studies revealed that a glycophospholipid is
covalently bound to the carboxyl terminus, suggesting that the
protein is integrated into the plasma membrane by this lipid
moiety. Lateral diffusion of Thy-1 was measured in mouse
thymocytes, lymphoma cells, and fibroblasts by the fluores-
cence recovery after photobleaching technique. Thy-i was
labeled with rhodamine-conjugated anti-Thy-1 monoclonal
antibodies. Diffusion coefficients of 24 x 10-9 cm2/sec were
obtained for the antigen-antibody complex in all the cell types.
About 50% of the Thy-1 was mobile. The diffusion coefficient
for the mobile fraction of Thy-1 is considerably larger than the
diffusion coefficients of many other plasma membrane pro-
teins. Rather, the diffusion coefficient of Thy-i is similar to
those of lipid analogs embedded in the same membrane,
providing strong support for the suggested lipid anchoring of
this antigen.
Lateral diffusion has been measured for various membrane
proteins of the plasma membrane of animal cells (1-3). In
most but not all cases, proteins have been found to diffuse
more slowly than expected based on protein diffusion in
artificial bilayers, suggesting that interactions between the
diffusant and other membrane proteins and/or peripheral
structures retard lateral mobility (2). Thy-1 is a membrane
glycoprotein that is present in copious amounts in rodent
thymocytes and brain cells (4). Since its primary sequence of
111 residues lacks hydrophobic sequences typical of mem-
brane-spanning proteins, it has been suggested that this
antigen is integrated in the bilayer by a nonpeptide protein
moiety (4). Very recent studies (5, 6) have revealed that, in
fact, a glycophospholipid is covalently bound to the carboxyl
terminus of Thy-1. The protein appears to be anchored in the
plasma membrane bilayer by this lipid tail. Although the
lateral diffusion of Thy-i had been measured (7, 8), the two
results yielded different diffusion coefficients. In light of the
striking new structural data and the previous discrepancy in
lateral diffusion results, we measured the lateral diffusion
coefficients of Thy-1 in thymocytes, lymphoma cells, and
fibroblasts by the fluorescence recovery after photobleaching
(FRAP) technique using fluorescent monoclonal antibodies
to tag the antigen. The diffusion coefficient for Thy-1 is >10
times greater than those measured for many other plasma
membrane proteins studied in the past; its diffusion coeffi-
cient is comparable to those of lipid analogs embedded in the
membrane. The rapid diffusion of Thy-1 is consistent with
putative lipid anchoring of the glycoprotein to the plasma
membrane bilayer.
MATERIALS AND METHODS
Antibodies. A rat monoclonal antibody (IgG) against Thy-i
(T24/40) was provided by I. Trowbridge (Salk Institute, San
Diego, CA). Antibody in ascites fluid was purified by am-
monium sulfate precipitation and conjugated with Lissamine
rhodamine B sulfonyl chloride (Molecular Probes, Junction
City, OR) as follows: 1 part of 1 M NaHCO3 (pH 9.0) was
added to 4 parts of phosphate-buffered saline (PBS; 140 mM
NaCl/2.7 mM KCI/8.1 mM Na2HPO4/1.5 mM KH2PO4/0.9
mM CaCl2/0.5 mM MgCl2, pH 7.4) containing the antibody
at a concentration of =1 mg/ml. The rhodamine was dis-
solved in 99% acetone and added slowly to the antibody; the
final ratio of rhodamine to protein was 50:1 (mol/mol), and
the final acetone concentration was <0.4%. The mixture was
incubated at room temperature for 20 min and centrifuged for
5 min to remove insoluble material. The antibody was
separated from free dye by passing the mixture through a
Pharmacia Sepharose G-50 fine column and eluting with PBS.
The antibody was dialyzed against PBS with a few grams of
Dowex 2-X8 per liter in the dialysis fluid for =36 hr to ensure
removal of any unconjugated dye. The molar ratio of
fluorochrome/protein ranged from 2.1:1 to 4.1:1.
Cells. Thymocytes were isolated from thymus of 6-week-
old mice. Lymphoma cell lines [AKRi/G1 (Thy-i+),
AKRi/GlM1 (Thy-1)] were generous gifts from I.
Trowbridge, and they were grown in Dulbecco's minimal
essential medium supplemented with 10% horse serum.
Mouse fibroblasts, C3H/1OT1/2 and BALB/3T3, were
grown on coverslips in Eagle's basal medium with Earle's
salts (GIBCO) plus 5-10% fetal bovine serum and Dulbecco's
minimal essential medium with 10% fetal bovine serum,
respectively. BG9 human fibroblasts were cultured on
coverslips in Eagle's minimal essential medium with Earle's
salts plus 10% fetal bovine serum. To immobilize lymphoma
cells and thymocytes on coverslips, these cells were washed
twice in PBS and deposited on coverslips pretreated with
0.1% poly-D-lysine.
Cells were stained with 20-60 ug of the conjugated
anti-Thy-1 antibody per ml and rinsed with PBS. They were
also stained with 1-acyl-2(N-4-nitrobenzo-2-oxa-1,3-diazole
aminocaproyl) phosphatidylcholine (NBD PtdCho; Avanti
Polar Lipids), which was dissolved in 99% ethanol, diluted in
PBS to 4 nM, and sonicated at 40C.
Fluorescence Recovery After Photobleaching (FRAP). Mea-
surement ofdiffusion coefficients by FRAP was essentially as
described (9). Briefly, this version of the method is based on
photobleaching a small circular region on the surface of single
cells bearing fluorescent molecules to destroy the emission
from that region. Subsequently, the recovery offluorescence
Abbreviations: FRAP, fluorescence recovery after photobleaching;
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due to the diffusion or flow of unbleached fluorophores from
the surrounding area into the irradiated area is measured.
When only isotropic lateral diffusion occurs, the recovery
kinetics, characterized by the time, ti12, to obtain 50% of full
recovery, are related to D, the diffusion coefficient by D =
W'2 y/4t,/2, where W14' the e-2 radius of the Gaussian pro-
file laser beam used i:oth photobleaching and measuring
fluorescence, and y i> xLrameter that depends on the extent
of photobleaching (1 te mobile fraction of the measured
population of probe rl iles is obtained from the degree to
which the final fluore - ; level approaches the pre-bleach
fluorescence value.
FRAP measurements re made with the x40 oil objective
(n.a., 1.3) on the photoL eaching microscope; the focussed
Gaussian laser beam radius was calculated to be -1 Am, and
this calculation was confirmed by quantitative fluorescence
microscopy using digital image processing. In this measure-
ment, the focussed beam was imaged by the fluorescence
excited from a thin film of 3,3'-dihexadecylindocarbocyanine
[dil-C16(3); see ref. 11] and its e2 width was obtained directly
from the beam intensity profile taken from the digitized image
(12). To measure the rapid (tl,2, <1 sec) fluorescence recov-
eries of Thy-1, a photon counter (Thorn EMI GenCom,
Fairfield, NJ) coupled to a multichannel analyzer (Nucleus,
Oak Ridge, TN) was used. Alternatively, analog detection
using an amplifier having a time constant of =20 msec and a
storage oscilloscope were used to record the fluorescence
recovery kinetics. Bleach times were from 37 to 150 msec;
bleach powers (at the laser) were from 8 to 200 mW at 515 nm.
The bleaching beam was attenuated by 100-fold or 1000-fold
for the recovery measurement. For the fibroblasts, a 350-,gm
pinhole in an intermediate image plane was used to limit the
collection depth of the photomultiplier. A 200-gum pinhole
was used to discriminate surfaces in the round thymocytes
and lymphoma cells. The measurements were done at room
temperature.
Antibody Dissociation. The dissociation rate of the labeled
antibody was estimated by measuring the decrease in fluo-
rescence intensity of stained thymocytes at various times
after labeling. The fluorescence intensity was measured with
a digitized fluorescence microscope, as described elsewhere
(12). Fluorescent images of given thymocytes were taken at
various times, and the area average fluorescence intensity
over that cell was obtained as a gray level average of the
pixels in the cell area. Corrections for fluorescence fading,
although very small, were made.
RESULTS
A rat monoclonal antibody (IgG) against murine Thy-1 was
conjugated with rhodamine. The specificity of the labeled
antibody was demonstrated by the lack of staining of BG-9
human fibroblasts and of a mutant Thy-1- lymphoma line
(AKR1/GlMi). Mouse thymocytes, Thy-1+ lymphoma
(AKR1/Gi), and fibroblasts (C3H/iOT1/2, BALB/3T3)
were stained diffusely, indicating that the antibody did not
induce crosslinking of the antigen. The antigens could be
patched by addition of a secondary anti-rat IgG antibody.
Almost all of the Thy-1 could be patched 1 hr after staining
with the monoclonal antibody, suggesting that most of the
antigen remained on the cell surface during the 1-hr period.
To exclude the possibility that surface hopping of the anti-
body accounts for the FRAP, the dissociation rate of the
antibody was estimated by measuring the decrease in fluo-
rescence intensity of thymocytes at various times after
labeling. The half-time for dissociation was 230 min; thus,
only 0.3% or less of the bound antibody was estimated to
dissociate within 6 sec, at which time the fluorescence
recoveries were largely completed.
Lateral diffusion of the Thy-1 was measured by the FRAP
technique as described (9). As shown in Table 1, the mea-
surements yielded a diffusion coefficient of 2-4 x 10-9
cm2/sec. All cell types gave similar values, although the
density of Thy-1 on fibroblasts was considerably less than on
thymocytes and lymphoma cells. A photometric measure-
ment by quantitative digitized fluorescence microscopy (11)
showed that the fluorescence per unit area in fibroblasts was
1/10th that in thymocytes. The mobile fractions ranged
from 40% to 60% in all the cell types.
In addition, the diffusion coefficient of Thy-1 was com-
pared to those for GP80, an 80-kDa integral membrane
glycoprotein (13), diI-C16(3), a lipid probe, and NBD PtdCho,
a phospholipid analog (Fig. 1A). All these measurements
were done in the same cell type, C3H/iOT1/2 mouse fibro-
blasts; the diffusion coefficients for dil-C16(3) and GP80 have
been published (9). GP80, a putative membrane-spanning
glycoprotein, has a small D value (1-2 x 10-10 cm2/sec)
typical of many membrane proteins, while the D value for
dil-C16(3) was -100 times greater. D for Thy-1 was nearly the
same as that for NBD PtdCho and almost 40 times larger than
D for GP80. The diffusion coefficient obtained for NBD
PtdCho was consistent with previous results (14). The cor-
responding mobile fractions for each diffusant are presented
in Fig. 1B. GP80 has a mobile fraction of =75% compared to
-50% for Thy-1, while the two lipid probes have mobile
fractions approaching 100%.
DISCUSSION
The lateral diffusion of Thy-1 was measured in three different
cell types by FRAP, and relatively large diffusion coefficients
(2-4 X 10-9 cm2/sec) were obtained for all the cell types. Two
measurements of Thy-1 lateral diffusion in lymphocytes have
been reported previously, but the results did not agree.
Dragsten et al. (7) reported slow (D - 10-10 cm2/sec)
diffusion, but the polyclonal rabbit anti-mouse brain antibody
used to label the antigen was not as well characterized as the
monoclonal anti-Thy-1 antibody used in this study. On the
other hand, Woda and Gilman (8) reported considerably
greater diffusion coefficients for Thy-1 using Fab fragments
of the monoclonal antibody MRC OX-7. However, their
measurements could be criticized on two counts. First, a
parallel determination of the diffusion coefficient for surface
immunoglobulin was larger than those reported ior this
protein in three previous studies by a factor of -3 (> 5, 16),
calling into question the measurement of rapid TbL- diffu-
sion. Second, the dissociation rate of this antibody t: .ment,
which may have been very rapid (17), was not m .-sured.
Such dissociation could have led to an artificially hign value
of the diffusion coefficient. Thus, in light of the striking new
structural data and the discordant previous diffusion results,
we believed a more extensive study was warranted.
The result for Thy-1 diffusion is in striking contrast to the
many previous measurements of sluggish glycoprotein lateral
diffusion (0.5 x 10-10 - D S 6 x 10-10 cm2/sec) for plasma
membrane proteins (1). Rather, the value is similar to those
Table 1. Diffusion coefficients and mobile fractions of Thy-1
Mobile
Cell type Line D (xl-9 cm2/sec) fraction, %
Fibroblast C3H/10T1/2 3.9 (±0.3) 46 (±4)
Fibroblast BALB/3T3 3.1 (±0.4) 45 (±9)
Thymocyte * 2.8 (±0.4) 55 (±6)
Lymphoma ARK1/G1 2.1 (±0.4) 43 (±4)
Diffusion coefficients and mobile fractions of the Thy-1 antigen
were measured by FRAP in various cell types. Values in parentheses
represent SEM.
*Isolated from mouse thymus.
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FIG. 1. Comparison of the Thy-1 diffusion coefficient (A) and
mobile fraction (B) with those of other molecules. dil-C16(3) and
NBD PtdCho are fluorescent lipid analogs. GP80 is a putative
transmembrane glycoprotein. The diffusion coefficients and mobile
fraction for these molecules in C3H/1OT1/2 cells were measured by
FRAP. Error bars represent SEM.
of lipid probes such as diI-C16(3) or NBD PtdCho. The
relatively large diffusion coefficient measured for Thy-1
probably reflects the recently proposed structure for the
molecule (5, 6) in which the glycoprotein is postulated to be
integral by virtue of a glycophospholipid tail and not by the
more typical hydrophobic membrane-spanning peptide. As-
suming that this lipid tail is not associated with another
membrane protein, diffusion of the lipid-linked glycoprotein
would not be expected to be limited by membrane-associated
cytoskeletal structure, as is the case, for example, with band
3 of the erythrocyte (18, 19). Its diffusion coefficient pre-
sumably is determined mainly by those factors that affect
lipid diffusion, such as lipid composition and integral protein
concentration (2, 20). It is of interest that a recent determi-
nation of the lateral mobility of another lipid-linked mem-
brane protein, decay accelerating factor (21), also yielded
large values of the diffusion coefficient (Z10-9 cm2/sec; see
ref. 22).
Since the lipid composition of viral envelopes reflects the
lipid composition of the host cell plasma membrane (23), the
lipid-linked structure and lipid-like lateral diffusion of Thy-1
may explain the observation that, of several major cell
membrane glycoproteins, only Thy-1 is found in the enve-
lopes of budding murine leukemia and vesicular stomatitis
viruses (24). In addition, the rapid lateral diffusion of Thy-1
may play a role in the quick increase in intracellular Ca2+
following antibody-mediated crosslinking of Thy-1 on lym-
phocytes (25).
The fact that the Thy-1 diffusion closely approaches that of
the lipid probes indicates that the size of the extracellular
ligand (i.e., the glycoprotein plus bound monoclonal anti-
body) and its possible interaction with the apposed extracel-
lular matrix does not appreciably retard diffusion. Earlier
measurements in artificial bilayers showed that the rate of
lipid diffusion was not hindered by the presence of antibody
bound to a haptenic group covalently linked to the lipid head
group (26). Our findings suggest a clearance of 40 to 140 A
between bilayer surface and the bulk of the extracellular
matrix structure. The minimum clearance (40 A) is estimated
by assuming that the 25-kDa glycoprotein moiety of Thy-1 is
spherical, having a diameter of -40 A, and the bound
antibody lays nearly flat on the membrane bilayer surface.
The maximum clearance (140 A) is estimated by assuming
that the antibody binding site is located on top of the
glycoprotein, allowing the IgG to extend maximally =100 A
further into the extracellular medium.
One contrast to the diffusion of lipid analogs in artificial
bilayers and in fibroblasts and to the diffusion of gangliosides
(27) in fibroblast membranes is that a substantial fraction of the
Thy-1 antigen was immobile. A substantial immobile fraction
was also measured for the lipid-linked decay accelerating factor
(22). An immobile fraction has been measured for lipid analog
diffusion in egg membranes (28) and has been quite generally
observed for plasma membrane glycoproteins (1). Several
possibilities, not mutually exclusive, exist to explain this im-
mobile fraction of Thy-1. (i) This fraction of the Thy-1 may be
functionally immobilized by being "trapped" in a lipid domain
or bound to another membrane protein that itself is immobilized
via interaction with peripheral structures. (ii) A fraction of the
antigen may be sterically trapped or specifically anchored in
certain local areas where the clearance between the membrane
and the extracellular matrix is smaller. (iii) The immobile
fraction may reflect the claim that at least part of the Thy-1
population is anchored by a hydrophobic peptide transmem-
brane segment (29). Some recent biochemical results bear on
these possible causes ofthe immobile fraction. The observation
that 10-20% ofThy-1 in T-lymphoma cells cannot be solubilized
by nonionic detergent was taken to suggest that this fraction of
the antigen is a constituent of a heteropolymeric complex of
detergent-resistant membrane proteins (30); this observation
supports any or all of the above possibilities. In addition, Low
and Kincade (5) reported that only =50%o of the Thy-1 antigen
on thymoma cells and thymocytes was digested by phospholi-
pase C. This result could be explained by extracellular matrix
components shielding the remaining sites from enzymatic at-
tack or by a portion of the protein population not being
lipid-linked (29).
The validity of the photobleaching techniques has been
questioned because many of the membrane protein diffusion
coefficients have been smaller than expected (31). Photodam-
age artefacts during the photobleaching step or the size ofthe
antibody ligand required to label the membrane protein have
been postulated to produce these retarding effects. Rapid
lateral diffusion might be expected for a glycoprotein, such as
Thy-1, which is presumed to be anchored to the membrane
via the glycolipid tail. It is reassuring that such rapid diffusion
was measured by FRAP in this study, suggesting that, at least
for the mobile fraction of Thy-1, the putative photodamage
and labeling ligand size effects are not appreciable. In fact,
recent FRAP measurements have shown that, under certain
conditions, the Na' channel (32) and a fraction of the murine
H-2 antigens (33) exhibit rapid lateral diffusion. Also, certain
protein antigens on the surface of guinea pig sperm (34) and
ram sperm (35) have diffusion coefficients in the range 10-9
to 10-8 cm2/sec. All ofthese results give credence to the view
that the range of lateral diffusion coefficients measured by
FRAP for various plasma membrane proteins are not
artefactual but have a biological origin and are worthy of
serious interpretation.
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